Based on existing literature, the most likely mechanism for VGSC function in cancer is a functional role in invadopodia, with potential downstream targets such as NHE, involved in ECM degradation, or voltage-gated calcium channels or NCX effecting calcium handling in the cell. The gene discussed is TLX2; the disease is cancer.